Relapse prevention in schizophrenia: does group family psychoeducation matter? One-year prospective follow-up field study

References

• Almond S, Knapp M, Francois C, et al. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 2004; 184: 346–51
   PubMed Web of Science ®Google Scholar
• Gilbert PL, Harris MJ, McAdams A, et al. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry 1995; 52(3)173–88
   PubMed Web of Science ®Google Scholar
• Leucht S, Barnes TR, Kissling W, et al. Relapse prevention in schizophrenia with new generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003; 160: 1209–22
   PubMed Web of Science ®Google Scholar
• Schooler NR. Relapse and rehospitalization: Comparing oral and depot antipsychotics. J Clin Psychiatry 2003; 64(Suppl 16)14–7
   PubMed Web of Science ®Google Scholar
• Pitschel-Walz G, Leucht S, Bauml J, et al. The effect of family interventions on relapse and rehospitalization in schizophrenia – A meta-analysis. Schizophr Bull 2001; 27(1)73–92
   PubMed Web of Science ®Google Scholar
• Leff J. First perceptions of treatment: The physician-family-patient network. J Prac Psych Behav Health 1996; 2(Suppl 1)10–15
   Google Scholar
• McFarlane WR, Lukens E, Link B. Multiple-family group and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995; 52: 679–87
   PubMed Web of Science ®Google Scholar
• Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand 1994; 382: 16–24
   Google Scholar
• Kissling W. Compliance, quality management and standards in the treatment of schizophrenia. Neuropsychobiology 1997; 35: 70–2
   Google Scholar
• Merinder LB, Viuff AG, Laugesen HD, et al. Patient and Relative education in community psychiatry: A randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol 1999; 34(6)287–94
   Web of Science ®Google Scholar
• Mueser KT, Torrey WC, Lynde D, et al. Implementing evidence-based practices for people with severe mental illness. Behav Modification 2003; 27(2)387–411
   Google Scholar
• Basan A, Pitschel-Walz G, Bauml J. Psychoeducational intervention for schizophrenic patients and subsequent long-term ambulatory care. A four-year follow-up. Fortschr Neurol Psychiatr 2000; 68(12)537–45
   Google Scholar
• Dixon L, Adams C, Lucksted A. Update on family psychoeducation for schizophrenia. Schizophr Bull 2000; 26(1)5–20
   PubMed Web of Science ®Google Scholar
• Dixon L, McFarlane WR, Lefley H, et al. Evidence-based practices for services to family members of people with psychiatric disabilities. Psychiatr Serv 2001; 52: 903–10
   PubMed Web of Science ®Google Scholar
• Ran MS, Xiang MZ, Chan CLW, et al. Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia. A randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 2003; 38: 69–75
   PubMed Web of Science ®Google Scholar
• Dyck DG, Hendryx MS, Short RA. Service use among patients with schizophrenia in psychoeducational multiple-family group treatment. Psychiatr Serv 2002; 53: 749–54
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984; 10(2)300–12
   PubMed Web of Science ®Google Scholar
• Hogarthy GE, Ulrich RF. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contribution of psychosocial treatment. J Psychiatr Res 1998; 32: 243–50
   Google Scholar
• Leff J, Kuipers L, Berkowitz RA. Controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry 1985; 146: 594–600
   PubMed Web of Science ®Google Scholar
• Možný P, Votýpková P. Expressed emotion, relapse rate and utilization of psychiatric inpatient care in schizophrenia. A study from Czechoslovakia. Soc Psychiatry Psychiatr Epidemiol 1992; 27(4)174–9
   Google Scholar
• Kavanagh D. Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992; 160: 601–20
   PubMed Web of Science ®Google Scholar
• Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse: A meta-analysis. Arch Gen Psychiatry 1998; 55: 547–52
   PubMed Web of Science ®Google Scholar
• Rosenfarb IS, Nuechterleein KH, Goldstein MJ, et al. Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Arch Gen Psychiatry 2000; 57(12)1174–9
   Google Scholar
• Motlova L. Psychoeducation as an indispensable complement to pharmacotherapy in schizophrenia. Pharmacopsychiatry ;(Suppl) 2000; 33: 47–8
   Google Scholar
• Motlova L, Dragomirecka E, Spaniel F, et al. Quality of life in schizophrenia with recent-onset: Patient-reported outcomes on group family psychoeducation. Abstract. Stating the art: Advancing outcomes research methodology and clinical applications. ISOQOL. 2004; 65
   Google Scholar
• Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment of Functioning scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766–71
   PubMed Web of Science ®Google Scholar
• Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64: 663–7
   PubMed Web of Science ®Google Scholar
• Thompson EE, Neighbors HW, Munday Ch, et al. Length of stay, referral to aftercare and re-hospitalization among psychiatric inpatients. Psychiatr Serv 2003; 54: 1271–6
   PubMed Web of Science ®Google Scholar
• Herz MI, Lamberti JS, Mintz J, et al. A program for relapse prevention in schizophrenia: A controlled study. Arch Gen Psychiatry 2000; 57(3)277–83
   Web of Science ®Google Scholar
• Feldman R, Hornung WP, Prein B, et al. Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 2002; 252: 115–9
   Google Scholar
• Mubarak AR, Barber JG. Emotional expressiveness and the quality of life of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2003; 38(7)380–4
   Google Scholar
• Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: A naturalistic study. Eur Neuropsychopharmacol 2002; 12: 31–8
   PubMed Web of Science ®Google Scholar
• Jablensky A. Epidemiology of schizophrenia: The global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000; 250: 274–85
   PubMed Web of Science ®Google Scholar
• Browne S, Clarke M, Gervin M, et al. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176: 173–6
   PubMed Web of Science ®Google Scholar
• Motlova L, Dragomirecka E, Spaniel F, et al. Schizophrenia and quality of life: Patient-reported outcomes on group family psychoeducation. Psychiatrie 2004; 8(Suppl 3)65–8
   Google Scholar
• McGorry PD, Edwards J, Miholopoulos C, et al. EPPIC: An evolving system of early detection and optimal management. Schizophr Bull 1996; 22: 305–26
   PubMed Web of Science ®Google Scholar
• Larsen TK, Friis S, Haahr U, et al. Early detection and intervention in first-episode schizophrenia: A critical review. Acta Psychiatr Scand 2001; 103: 323–34
   PubMed Web of Science ®Google Scholar
• Carbone S, Harrigan S, McGorry PD, et al. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: The impact of treatment approach. Acta Psychiatr Scand 1999; 100: 96–104
   PubMed Web of Science ®Google Scholar